GRI Bio, Inc. ( GRI) - Key Metrics
GRI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.91 | -$0.80 | -$0.80 |
| 2026Q1 | $0 | -$1.61 | -$2.97 | -$2.97 |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$5.34 | -$5.97 | -$5.98 |
| 2025Q3 | $0 | -$35.88 | -$24.70 | -$24.70 |
GRI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.49 |
| 2026Q1 | 0% | -0.34 |
| 2026Q1 | ? | ? |
| 2025Q4 | 0% | -0.15 |
| 2025Q3 | 0% | -0.33 |
GRI
Price: $1.71
52 week price:
Earnings Per Share: 38.89 USD
P/E Ratio: 0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2375
Market Capitalization: 3.0 million